GordonMD Global Investments LP - 13 Nov 2025 SCHEDULE 13G Report for Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX)

Filing Manager: GordonMD Global Investments LP
Reporting Manager: GordonMD Global Investments LP
Security: Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol: KYTX
Shares outstanding: 43,692,643 shares
Disclosed Ownership: 3,058,485 shares
Ownership: 7%
Form type: SCHEDULE 13G
Filing time: 17 Nov 2025, 15:41:11 UTC
Date of event: 13 Nov 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
GordonMD Global Investments LP	7%	3,058,485	3,058,485	/s/ GordonMD Global Investments GP LLC	Craig D. Gordon / Managing Member of the General Partner
GordonMD Long Biased Master Fund LP	6.2%	2,735,783	2,735,783	/s/ GordonMD Long Biased GP LLC	GordonMD Long Biased GP LLC / Managing Member of the General Partner
GordonMD Long Biased GP LLC	6.2%	2,735,783	2,735,783	/s/ Craig D. Gordon	Craig D. Gordon / Managing Member
Craig D. Gordon	7%	3,058,485	3,058,485	/s/ Craig D. Gordon	Craig D. Gordon
GordonMD Global Investments GP LLC	7%	3,058,485	3,058,485	/s/ Craig D. Gordon	Craig D. Gordon / Managing Member